1. Propranolol in the preoperative treatment of Kasabach-Merritt syndrome: a case report.
- Author
-
Radović SV, Kolinović M, and Ljubić D
- Subjects
- Combined Modality Therapy methods, Female, Humans, Infant, Treatment Outcome, Adrenergic beta-Antagonists therapeutic use, Kasabach-Merritt Syndrome drug therapy, Kasabach-Merritt Syndrome surgery, Preoperative Care methods, Propranolol therapeutic use
- Abstract
Background: Kasabach-Merritt syndrome represents the association of hemangioma with thrombocytopenia and consumptive coagulopathy. We present a case of Kasabach-Merritt syndrome treatment with orally administered propranolol., Case Presentation: A 4.5-month-old caucasian female infant with congenital giant hemangioma in the posterior region of her neck presented to our Institute for Childhood Diseases where she underwent clinical, laboratory, and radiological investigations. A low blood platelet count indicated the use of corticosteroids and blood components as first-line therapy. The lack of therapeutic response induced the introduction of orally administered propranolol as additive therapy. A 3-week treatment led to a reduction in the size of hemangioma and a rise in platelet count which enabled surgical treatment and definite healing., Conclusion: Orally administered propranolol as monotherapy or in combination with other therapeutic modalities may play a key role in the treatment of Kasabach-Merritt syndrome.
- Published
- 2017
- Full Text
- View/download PDF